Just look how MSB updats the market and provide deadline:
"
”We are committed to making our FDA approved product Ryoncil® available as quickly as possible to the
many children with SR-aGVHD in need of life-saving therapy,” said Dr. Silviu Itescu, Chief Executive of
Mesoblast. “The team has been working relentlessly on finalizing product availability, including logistics,
regulatory documentation, and contractual arrangements to ensure a successful launch of Ryoncil® this
quarter.”
“The successful financing of US$160 million (A$260 million) this month, which provides the Company
with proforma cash on hand of approximately US$200 million (A$322 million), puts us in a strong
position to execute the U.S. commercial launch activities of Ryoncil®, to expand the clinical indications
of the product, and ensure that commercial manufacturing will meet projected product uptake and
demand.”
“I look forward to providing an update at half year results on February 27th 9.00am AEDT (February 26th
5.00pm EST).”
"
Biotron needs to provide similar deadline to update the market with something of value. Silence means something or most of the things may be missing! If anything missing, SHs have the right to know.
(20min delay)